BioMaxima S.A. (WSE:BMX)

Market Cap	58.28M
Revenue (ttm)	56.64M
Net Income (ttm)	874.00K
Shares Out	4.19M
EPS (ttm)	0.21
PE Ratio	66.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,248
Average Volume	16,022
Open	14.80
Previous Close	14.60
Day's Range	13.50 - 14.85
52-Week Range	10.55 - 20.50
Beta	0.46
RSI	50.49
Earnings Date	Jun 3, 2025

About BioMaxima

BioMaxima S.A. manufactures and distributes microbiological media, reagents, and equipment for in vitro diagnostics in Poland. Its primary products include analyzers and diagnostic reagents for testing the biochemical parameters of blood and other body fluids; systems for the determination of drug resistance of microorganisms; quick diagnostic tests for detecting infectious diseases, cancer markers, heart attack markers, and addictive substances and readers; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and r...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 126
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: BMX

Financial Performance

In 2024, BioMaxima's revenue was 52.85 million, an increase of 12.96% compared to the previous year's 46.79 million. Earnings were 535,000, a decrease of -8.70%.